Canada vs Mongolia: Proportion of isolates with decreased susceptibility or resistance
Canada
1.4
in 2020
Mongolia
0.7752
in 2018
Canada rank
7th
Mongolia rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Canada
- Mongolia
How they compare
Canada currently reports 1.4 against 0.7752 in Mongolia, a difference of 0.6248.
That makes Canada's figure about 1.8 times Mongolia's.
The two have swapped places 2 times across 6 shared years of data; in 2009 it was Mongolia ahead.
Canada ranks 7th and Mongolia ranks 9th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.09 | 19.13 | 16.04 | Mongolia |
| 2010s | 2.71 | 11.33 | 8.62 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Canada or Mongolia?
- Canada, at 1.4 against 0.7752 in Mongolia as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Canada and Mongolia?
- 0.6248, with Canada ahead.
- How many years of comparable data are there for Canada and Mongolia?
- 6 years are reported by both, from 2009 to 2018.
- How do Canada and Mongolia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Canada ranks 7th and Mongolia ranks 9th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.